HIV/AIDS Prevention and Control in India: Achievements and Future Challenges.

IF 4.6 2区 医学 Q1 CHEMISTRY, MEDICINAL Expert Opinion on Therapeutic Patents Pub Date : 2015-12-01 DOI:10.4103/1947-2714.172853
Harshal T Pandve, Purushottam A Giri
{"title":"HIV/AIDS Prevention and Control in India: Achievements and Future Challenges.","authors":"Harshal T Pandve, Purushottam A Giri","doi":"10.4103/1947-2714.172853","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12314,"journal":{"name":"Expert Opinion on Therapeutic Patents","volume":"9 1","pages":"575-6"},"PeriodicalIF":4.6000,"publicationDate":"2015-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755085/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Opinion on Therapeutic Patents","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/1947-2714.172853","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
印度的艾滋病毒/艾滋病预防和控制:成就与未来挑战》。
根据世界卫生组织(卫生组织)的资料,人类免疫缺陷病毒(艾滋病毒)仍然是一个主要的全球公共卫生问题,迄今已夺去3 900多万人的生命。2013年,全球有150万人死于与艾滋病毒相关的原因。截至2013年底,约有3500万人感染艾滋病毒,2013年全球有210万人(190 - 240万人)新感染艾滋病毒印度是世界上第三大艾滋病流行国。2013年,印度的艾滋病毒流行率估计为0.3%本文简要讨论了印度在预防和控制艾滋病方面取得的成就,以及印度未来面临的挑战。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
12.10
自引率
1.50%
发文量
50
审稿时长
6-12 weeks
期刊介绍: Expert Opinion on Therapeutic Patents (ISSN 1354-3776 [print], 1744-7674 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on recent pharmaceutical patent claims, providing expert opinion the scope for future development, in the context of the scientific literature. The Editors welcome: Reviews covering recent patent claims on compounds or applications with therapeutic potential, including biotherapeutics and small-molecule agents with specific molecular targets; and patenting trends in a particular therapeutic area Patent Evaluations examining the aims and chemical and biological claims of individual patents Perspectives on issues relating to intellectual property The audience consists of scientists, managers and decision-makers in the pharmaceutical industry and others closely involved in R&D Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days.
期刊最新文献
PCSK9 inhibitors: an updated patent review 2024-2025. Recent advances in the discovery of PKMYT1-targeting drugs: a patent review (2021-2025). An updated patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2020-2025). An update on PDGFR inhibitors: a patent review (2020 - present). A patent review of LPAR1 antagonists (2010 - present).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1